Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial and Angiogenic Biomarkers in Obstructive Sleep Apnea: Longitudinal Associations With Continuous Positive Airway Pressure.

Archivos de bronconeumologia·2026
Same author

[2027: A new year for a new epidemiological study of chronic obstructive pulmonary disease in Spain].

Open respiratory archives·2026
Same author

Environmental Regulation and Gene-by-Environment Interaction Influence <i>RAP1</i> Activity and its Impact on Gene Expression.

bioRxiv : the preprint server for biology·2026
Same author

Screening obstructive sleep apnea using clinical questionnaires and the triglyceride-glucose index: a cardiovascular risk-based approach.

NPJ primary care respiratory medicine·2026
Same author

Nocturnal blood pressure patterns in pediatric obstructive sleep apnea: The Kids Trial study.

Sleep medicine·2026
Same author

Sex-specific APOE4-dependent innate immunity regulates meningeal lymphatics, brain lipids, neuroinflammation, and cognition.

Neuron·2026

Related Experiment Video

Updated: Jun 12, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.

Francisco Garcia-Rio1, Marc Miravitlles, Joan B Soriano

  • 1Pneumology Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain. fgr01m@gmail.com

Respiratory Research
|May 27, 2010
PubMed
Summary

This study found that Chronic Obstructive Pulmonary Disease (COPD) patients exhibit higher levels of systemic inflammation biomarkers compared to healthy individuals. These inflammatory markers are linked to COPD severity and impact exercise tolerance.

Related Experiment Videos

Last Updated: Jun 12, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Biomarker Research

Background:

  • Elevated inflammatory biomarkers are noted in some COPD patients, but population-based data is limited.
  • Understanding systemic inflammation in COPD is crucial for disease management.

Purpose of the Study:

  • To compare systemic inflammatory biomarker levels between COPD patients and healthy individuals in a population-based sample.
  • To investigate the relationship between these biomarkers and clinical variables in COPD.

Main Methods:

  • Cross-sectional study of 324 COPD patients and 110 healthy controls (ages 40-80).
  • Exclusion of subjects with other inflammatory conditions.
  • Measurement of serum C-reactive protein (CRP), TNF-alpha, IL-6, IL-8, alpha1-antitrypsin, fibrinogen, albumin, and NOx.

Main Results:

  • COPD patients showed significantly higher levels of CRP, TNF-alpha, IL-8, and NOx compared to controls after adjusting for confounders.
  • Biomarker concentrations correlated with COPD severity.
  • Exercise tolerance in COPD patients was associated with CRP, IL-6, IL-8, fibrinogen, and albumin levels.

Conclusions:

  • COPD is independently associated with low-grade systemic inflammation.
  • A distinct inflammatory biomarker profile exists in COPD patients compared to healthy subjects.